XOMA Royalty Corp. (XOMA)
25.81
+1.41
(+5.78%)
USD |
NASDAQ |
Feb 20, 16:00
25.83
+0.02
(+0.08%)
After-Hours: 20:00
XOMA Royalty SG&A Expense (Quarterly) : 9.734M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 61.91M |
| Recursion Pharmaceuticals, Inc. | 41.63M |
| Rezolute, Inc. | 9.873M |
| DiaMedica Therapeutics, Inc. | 2.596M |
| Gossamer Bio, Inc. | 9.39M |